J&J: EPS targets lowered for 2024

(CercleFinance.com) - Johnson & Johnson (J&J) says it now expects adjusted EPS of between $9.
88 and $9.98 for the current full year, compared with a previous target range of $9.97 to $10.07, due to costs associated with the V-Wave acquisition.

The healthcare group explains that these costs more than offset improved performance and the effect of the V-Wave acquisition, leading it to raise its target range for adjusted operating sales growth by 0.2 point to between 5.7% and 6.2%.

Johnson & Johnson reports Q3 2024 adjusted EPS that is down 9% to $2.42, on revenues up 5.2% to $22.5bn (+5.4% in adjusted operating growth).


Copyright (c) 2024 CercleFinance.com. All rights reserved.